Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7517)
All Articles published online
|
Publishing Process of This Article
|
Apr 7, 2013 (publication date) through Dec 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen J, Zhou SJ, Zhang Y, Zhang GQ, Zha TZ, Feng YZ, Zhang K. Clinicopathological and prognostic significance of galectin-1 and vascular endothelial growth factor expression in gastric cancer. World J Gastroenterol 2013; 19(13): 2073-2079 [PMID: 23599627 DOI: 10.3748/wjg.v19.i13.2073] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i13/2073.htm |
| Number | Citing Articles |
| 1 |
Pradeep Madhamanchi, Kishore Madhamanchi, Sujatha Peela, Panchareddy Madhava Rao, Pallaval Veera Bramhachari, Prakash Babu Panithi. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; : 255 doi: 10.1016/B978-0-323-98807-0.00021-1
|
| 2 |
Annie A Wu, Virginia Drake, Huai-Shiuan Huang, ShihChi Chiu, Lei Zheng. Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells. OncoImmunology 2015; 4(7): e1016700 doi: 10.1080/2162402X.2015.1016700
|
| 3 |
María José Carlini, Pablo Roitman, Myriam Nuñez, María Guadalupe Pallotta, Gastón Boggio, David Smith, Mariana Salatino, Elisa D. Bal de Kier Joffé, Gabriel A. Rabinovich, Lydia I. Puricelli. Clinical relevance of galectin-1 expression in non-small cell lung cancer patients. Lung Cancer 2014; 84(1): 73 doi: 10.1016/j.lungcan.2014.01.016
|
| 4 |
Lucile Astorgues-Xerri, Maria E. Riveiro, Annemilaï Tijeras-Raballand, Maria Serova, Gabriel A. Rabinovich, Ivan Bieche, Michel Vidaud, Armand de Gramont, Mathieu Martinet, Esteban Cvitkovic, Sandrine Faivre, Eric Raymond. OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis. European Journal of Cancer 2014; 50(14): 2463 doi: 10.1016/j.ejca.2014.06.015
|
| 5 |
Stefan Kasper, Martin Schuler. Cancer Immunotherapy Meets Oncology. 2014; : 179 doi: 10.1007/978-3-319-05104-8_17
|
| 6 |
Jonathan W. Riess, Christina S. Kong, Robert B. West, Sukhmani K. Padda, Joel W. Neal, Heather A. Wakelee, Quynh-Thu Le. Increased Galectin-1 Expression in Thymic Epithelial Tumors. Clinical Lung Cancer 2019; 20(3): e356 doi: 10.1016/j.cllc.2018.12.005
|
| 7 |
Rongzu Wu, Tingchun Wu, Kai Wang, Shicheng Luo, Zhen Chen, Min Fan, Dong Xue, Hao Lu, Qianfeng Zhuang, Xianlin Xu. Prognostic significance of galectin-1 expression in patients with cancer: a meta-analysis. Cancer Cell International 2018; 18(1) doi: 10.1186/s12935-018-0607-y
|
| 8 |
Bo Long, Zeyuan Yu, Huinian Zhou, Zhijian Ma, Yanxian Ren, Hao Zhan, Long Li, Hongtai Cao, Zuoyi Jiao. Clinical characteristics and prognostic significance of galectins for patients with gastric cancer: A meta-analysis. International Journal of Surgery 2018; 56: 242 doi: 10.1016/j.ijsu.2018.06.033
|
| 9 |
Ali Akbar Esmailiejah, Afshin Taheriazam, Mohammad Reza Golbakhsh, Mohammad Jamshidi, Mohammadreza Shakeri, Emad Yahaghi, Mehdi Moghtadaei. RETRACTED ARTICLE: Analysis of serum levels and tissue expression of galectin-1 and galectin-3 as noninvasive biomarkers in osteosarcoma patients. Tumor Biology 2016; 37(12): 16389 doi: 10.1007/s13277-015-4194-4
|
| 10 |
Stefan Kasper, Martin Schuler. Targeted therapies in gastroesophageal cancer. European Journal of Cancer 2014; 50(7): 1247 doi: 10.1016/j.ejca.2014.01.009
|
| 11 |
Reza Ranjbar, Foroogh Nejatollahi, Ahmad Sina Nedaei Ahmadi, Hossein Hafezi, Akbar Safaie. Expression of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) in Patients With Serous Ovarian Carcinoma and Their Clinical Significance. Iranian Journal of Cancer Prevention 2015; 8(4) doi: 10.17795/ijcp-3428
|
| 12 |
Tiago Ferreira, Amit Kulkarni, Clemens Bretscher, Petr Nazarov, Jubayer Hossain, Lars Ystaas, Hrvoje Miletic, Ralph Röth, Beate Niesler, Antonio Marchini. Oncolytic H-1 Parvovirus Hijacks Galectin-1 to Enter Cancer Cells. Viruses 2022; 14(5): 1018 doi: 10.3390/v14051018
|
| 13 |
Lara Alessandrini, Melissa Manchi, Valli De Re, Riccardo Dolcetti, Vincenzo Canzonieri. Proposed Molecular and miRNA Classification of Gastric Cancer. International Journal of Molecular Sciences 2018; 19(6): 1683 doi: 10.3390/ijms19061683
|
| 14 |
Lucile Astorgues-Xerri, Maria E. Riveiro, Annemilaï Tijeras-Raballand, Maria Serova, Cindy Neuzillet, Sébastien Albert, Eric Raymond, Sandrine Faivre. Unraveling galectin-1 as a novel therapeutic target for cancer. Cancer Treatment Reviews 2014; 40(2): 307 doi: 10.1016/j.ctrv.2013.07.007
|
| 15 |
Ismael Riquelme, Kathleen Saavedra, Jaime A. Espinoza, Helga Weber, Patricia García, Bruno Nervi, Marcelo Garrido, Alejandro H. Corvalán, Juan Carlos Roa, Carolina Bizama. Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy. Oncotarget 2015; 6(28): 24750 doi: 10.18632/oncotarget.4990
|
| 16 |
Zhaohui Jin, Harry H. Yoon. Antiangiogenic Therapy in Gastroesophageal Cancer. Hematology/Oncology Clinics of North America 2017; 31(3): 499 doi: 10.1016/j.hoc.2017.01.008
|
| 17 |
Yu-Li Su, Hao-Lun Luo, Chun-Chieh Huang, Ting-Ting Liu, Eng-Yen Huang, Ming-Tse Sung, Jen-Jie Lin, Po-Hui Chiang, Yen-Ta Chen, Chih-Hsiung Kang, Yuan-Tso Cheng. Galectin-1 Overexpression Activates the FAK/PI3K/AKT/mTOR Pathway and Is Correlated with Upper Urinary Urothelial Carcinoma Progression and Survival. Cells 2020; 9(4): 806 doi: 10.3390/cells9040806
|
| 18 |
Sadhna Aggarwal, Suresh C. Sharma, Satya N. Das. Galectin-1 and galectin-3: Plausible tumour markers for oral squamous cell carcinoma and suitable targets for screening high-risk population. Clinica Chimica Acta 2015; 442: 13 doi: 10.1016/j.cca.2014.12.038
|
| 19 |
Hong Jun Kim, Sang Cheul Oh. Novel Systemic Therapies for Advanced Gastric Cancer. Journal of Gastric Cancer 2018; 18(1): 1 doi: 10.5230/jgc.2018.18.e3
|
| 20 |
Victor L. Thijssen, Roy Heusschen, Jo Caers, Arjan W. Griffioen. Galectin expression in cancer diagnosis and prognosis: A systematic review. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2015; 1855(2): 235 doi: 10.1016/j.bbcan.2015.03.003
|
| 21 |
Lara Alessandrini, Melissa Manchi, Fabrizio Italia, Tiziana Perin, Vincenzo Canzonieri. Gastric Cancer In The Precision Medicine Era. Current Clinical Pathology 2019; : 155 doi: 10.1007/978-3-030-04861-7_10
|
| 22 |
Elizabeth Cartwright, Avani Athauda, Ian Chau. Emerging precision therapies for gastric cancer. Expert Review of Precision Medicine and Drug Development 2020; 5(4): 299 doi: 10.1080/23808993.2020.1760089
|
| 23 |
Jia Li, Xiaopan Yao, Jeremy S. Kortmansky, Neal A. Fischbach, Stacey Stein, Yanhong Deng, Yue Zhang, Indukala Doddamane, David Karimeddini, Howard S. Hochster, Jill Lacy. Phase II Study of Modified FOLFOX6 With Bevacizumab in Metastatic Gastroesophageal Adenocarcinoma. American Journal of Clinical Oncology 2017; 40(2): 146 doi: 10.1097/COC.0000000000000114
|
| 24 |
Cherylane Dubé-Delarosbil, Yves St-Pierre. The emerging role of galectins in high-fatality cancers. Cellular and Molecular Life Sciences 2018; 75(7): 1215 doi: 10.1007/s00018-017-2708-5
|
| 25 |
Mariana Ferreira Leal, Fernanda Wisnieski, Carolina de Oliveira Gigek, Leonardo Caires do Santos, Danielle Queiroz Calcagno, Rommel Rodriguez Burbano, Marilia Cardoso Smith. What gastric cancer proteomic studies show about gastric carcinogenesis?. Tumor Biology 2016; 37(8): 9991 doi: 10.1007/s13277-016-5043-9
|
| 26 |
Yang Chong, Dong Tang, Jun Gao, Xuetong Jiang, Chuanqi Xu, Qingquan Xiong, Yuqin Huang, Jie Wang, Huaicheng Zhou, Youquan Shi, Daorong Wang. Galectin-1 induces invasion and the epithelial-mesenchymal transition in human gastric cancer cells via non-canonical activation of the hedgehog signaling pathway. Oncotarget 2016; 7(50): 83611 doi: 10.18632/oncotarget.13201
|
| 27 |
Alexandra Thiel, Ari Ristimäki. Targeted therapy in gastric cancer. APMIS 2015; 123(5): 365 doi: 10.1111/apm.12359
|
| 28 |
Kun Zou, Shuailong Yang, Liang Zheng, Chaogang Yang, Bin Xiong. Efficacy and safety of target combined chemotherapy in advanced gastric cancer: a meta-analysis and system review. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2772-5
|
| 29 |
Cristina Díaz del Arco, Lourdes Estrada Muñoz, María de los Ángeles Cerón Nieto, Elena Molina Roldán, María Jesús Fernández Aceñero, Soledad García Gómez de las Heras. Prognostic Influence of Galectin-1 in Gastric Adenocarcinoma. Biomedicines 2024; 12(7): 1508 doi: 10.3390/biomedicines12071508
|
| 30 |
Ya-nan Ji, Qin Wang, Yang Li, Zhi Wang. Prognostic value of vascular endothelial growth factor A expression in gastric cancer: a meta-analysis. Tumor Biology 2014; 35(3): 2787 doi: 10.1007/s13277-013-1371-1
|
| 31 |
Tingrui Zheng, Tao Qian, Haihua Zhou, Zhiyi Cheng, Guiyuan Liu, Chuanjiang Huang, Rongrong Dou, Fuxing Liu, Xiaolan You. Galectin-1-mediated high NCAPG expression correlates with poor prognosis in gastric cancer. Aging 2023; doi: 10.18632/aging.204806
|
| 32 |
Paulina Sindrewicz, Lu-Yun Lian, Lu-Gang Yu. Interaction of the Oncofetal Thomsen–Friedenreich Antigen with Galectins in Cancer Progression and Metastasis. Frontiers in Oncology 2016; 6 doi: 10.3389/fonc.2016.00079
|
| 33 |
Kun‐Hung Shen, Chien‐Feng Li, Lan‐Hsiang Chien, Cheng‐Hao Huang, Chia‐Cheng Su, Alex C. Liao, Ting‐Feng Wu. Role of galectin‐1 in urinary bladder urothelial carcinoma cell invasion through the JNK pathway. Cancer Science 2016; 107(10): 1390 doi: 10.1111/cas.13016
|
| 34 |
Hua Tian, Yan Zhou, Gaoxiang Yang, Yang Geng, Sai Wu, Yabin Hu, Kai Lin, Wei Wu. Sulforaphane-cysteine suppresses invasion via downregulation of galectin-1 in human prostate cancer DU145 and PC3 cells. Oncology Reports 2016; 36(3): 1361 doi: 10.3892/or.2016.4942
|
| 35 |
|
| 36 |
Suk-young Lee, Sang Cheul Oh. Changing strategies for target therapy in gastric cancer. World Journal of Gastroenterology 2016; 22(3): 1179-1189 doi: 10.3748/wjg.v22.i3.1179
|
| 37 |
Changhui Zhou, Weihua Wang, Ying Mu, Min Meng. Efficacy and safety of a novel TKI (anlotinib) for the treatment of advanced digestive system neoplasms: a systematic review and meta-analysis. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1393404
|
| 38 |
Neha Merchant, Ganji Purnachandra Nagaraju. Novel therapeutic approaches for gastrointestinal malignancies. Diagnostics and Therapeutic Advances in GI Malignancies 2020; : 1 doi: 10.1007/978-981-15-5471-1_1
|
| 39 |
Ming‐Yu Huang, Jia‐Peng He, Wen‐Qian Zhang, Ji‐Long Liu. Pooling analysis reveals that galectin‐1 is a reliable prognostic biomarker in various cancers. Journal of Cellular Physiology 2019; 234(8): 13788 doi: 10.1002/jcp.28059
|